323 related articles for article (PubMed ID: 18677030)
1. Universal access to HIV/AIDS treatment: promise and problems.
Jaffe HW
JAMA; 2008 Aug; 300(5):573-5. PubMed ID: 18677030
[No Abstract] [Full Text] [Related]
2. [Access to treatment of HIV/AIDS in the South: the challenges of sustainability].
Kazatchkine M; Moatti JP
Med Sci (Paris); 2008 Dec; 24(12):1007-8. PubMed ID: 19116101
[No Abstract] [Full Text] [Related]
3. Crunch time for funding of universal access to antiretroviral treatment for people with HIV infection.
Maher D; von Schoen-Angerer T; Cohn J
Int J Clin Pract; 2011 Aug; 65(8):824-7. PubMed ID: 21762306
[No Abstract] [Full Text] [Related]
4. Stretching the AIDS dollar.
Chatterjee P
Lancet; 2009 Aug; 374(9691):678. PubMed ID: 19725169
[No Abstract] [Full Text] [Related]
5. HIV/AIDS. Universal access in the fight against HIV/AIDS.
Girard F; Ford N; Montaner J; Cahn P; Katabira E
Science; 2010 Jul; 329(5988):147-9. PubMed ID: 20616254
[No Abstract] [Full Text] [Related]
6. Public health. Global HIV/AIDS policy in transition.
Bongaarts J; Over M
Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
[No Abstract] [Full Text] [Related]
7. UN political declaration on HIV and AIDS: where to begin?
Poku NK
Lancet; 2016 Aug; 388(10046):743-4. PubMed ID: 27560262
[No Abstract] [Full Text] [Related]
8. Global AIDS conference finds the issue is cash.
Cullinan K
Bull World Health Organ; 2002; 80(9):761-2. PubMed ID: 12378299
[No Abstract] [Full Text] [Related]
9. HIV/AIDS. The great funding surge.
Cohen J
Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
[No Abstract] [Full Text] [Related]
10. A strategic revolution in HIV and global health.
Lancet; 2011 Jun; 377(9783):2055. PubMed ID: 21684364
[No Abstract] [Full Text] [Related]
11. Funding for HIV/AIDS needs to double to ensure universal access to drugs.
Dyer C
BMJ; 2009 Feb; 338():b583. PubMed ID: 19211637
[No Abstract] [Full Text] [Related]
12. Ensuring access to essential medicines: some economic considerations.
Maskus KE
Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
[No Abstract] [Full Text] [Related]
13. HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.
Maponga CC; Ma Q; Slish JC; Morse GD
Top HIV Med; 2007; 15(3):104-10. PubMed ID: 17598930
[TBL] [Abstract][Full Text] [Related]
14. Universal access to HIV treatment will not be achieved by 2015 without radical action.
Moszynski P
BMJ; 2010 Mar; 340():c1483. PubMed ID: 20236994
[No Abstract] [Full Text] [Related]
15. Affordable antiretroviral drugs for developing countries: dreams of the magic bullet.
Razum O; Okoye S
Trop Med Int Health; 2001 Jun; 6(6):421-2. PubMed ID: 11422954
[No Abstract] [Full Text] [Related]
16. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
17. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
18. Universal access to antiretroviral therapy: when, not if.
Carpenter CC
Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
[No Abstract] [Full Text] [Related]
19. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
20. [Are anti-HIV agents the salvation for poor countries?].
Lien L
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1714-6. PubMed ID: 12821995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
